Data / Form D filings / SANIA THERAPEUTICS, INC.
SANIA THERAPEUTICS, INC.: Form D filings
SANIA THERAPEUTICS, INC., a biotechnology company in London, United Kingdom, filed 3 Form D notices with the SEC between 2022 and 2024. The latest, on May 21, 2024, reports $5 million sold of a $7.5 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- C/O SANIA RX LTD, WATERFRONT BUILDING, MANBRE WHARF, London, United Kingdom, W6 9R
- Phone
- 011442033988924
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1901599
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 21, 2024 | New notice | $7,500,000 | $4,999,995 | $2,500,005 | 4 | May 6, 2024 | sec.gov |
| Mar 8, 2023 | New notice | $2,000,000 | $1,500,000 | $500,000 | 9 | Feb 21, 2023 | sec.gov |
| Mar 23, 2022 | New notice | $5,046,995 | $5,046,995 | 14 | Mar 18, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Mark Evans | Director | |
| Andrew Murray | Executive Officer, Director | |
| Joseph Korff | Director | |
| Robert Brownstone | Director |
Every Form D from the week of May 20, 2024 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what SANIA THERAPEUTICS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.